[1]
C. Lertanansit, “The Efficacy of the second Line Docetaxel in Previously Treated with Standard First Line Combination Carboplatin and Gemcitabine versus Carboplatin and Paclitaxel in Patients Diagnosed with Advanced Stage Non-Small Cell Lung Cancer (NSCLC), A Retrospective Study”, Med J Sisaket Surin Buriram Hosp., vol. 37, no. 3, pp. 589–597, Dec. 2022.